A

Actinium Pharmaceuticals, IncATNM

Actinium is a pioneer in targeted radiotherapies designed to improve outcomes for patients with cancer. The company employs a biology-driven approach to develop differentiated radiopharmaceuticals for solid tumors and hematologic malignancies. Its mission is to transform cancer treatment through innovative radioconjugates that maximize therapeutic efficacy while minimizing toxicity to healthy tissue by combining expertise in tumor biology, translational medicine, and.

US StocksHealthcareSmall CapBiotechnology

ATNM の価格トレンド

Actinium Pharmaceuticals, Inc · TradingView フルチャート

NASDAQ:ATNM

オンチェーンアクティビティ